What is the significance of this filing being an amendment (10-Q/A)?

A 10-Q/A filing means that Amgen Inc. is amending a previously filed quarterly report (10-Q). This indicates that there were either errors, omissions, or a need for clarification in the original filing. Investors should carefully review the amendment to understand what specific information has been changed or added.

Where can I find the actual financial details of this report?

The provided text is a directory listing of the SEC filing's components. To access the actual financial statements, management discussion, and other detailed information, you would need to download the full 10-Q/A document from the SEC's EDGAR database using the filing date and company information.

What kind of information might be corrected or clarified in an amendment?

Amendments can cover a wide range of items, including corrections to revenue or expense figures, changes in accounting policies or estimates, updates to legal proceedings, or clarifications of previously disclosed business strategies or risks.

AMGN 10-Q Quarterly Report Q2 FY1998 — Revenue, Net Income, EPS

Summary

Amgen Inc.'s (AMGN) amended 10-Q filing for the period ending June 29, 1998, primarily serves as an update or correction to previously filed information. While the provided text is a directory listing and does not contain the financial statements or detailed narrative, it indicates an amendment was filed on August 17, 1998. Investors should look for the specific reasons for the amendment, which often relate to clarifications of financial results, accounting policies, or disclosures. The nature of an amendment suggests careful attention is warranted to understand any changes from the initial filing.

Key Highlights

1The filing is an amendment (10-Q/A) to Amgen Inc.'s quarterly report.
2The period ending date is June 29, 1998.
3The amendment was filed on August 17, 1998.
4The provided content is a directory listing of the filing's components, not the financial statements themselves.
5Amendments typically signal a need for investors to review specific changes from the original filing.
6Investors should seek the actual amended 10-Q document to understand the details of the revisions.

AMGEN INC Quarterly Report (Amendment) for Q2 Ended Jun 30, 1998

Summary

Key Highlights

Frequently Asked Questions